Upregulation of RIG ‐I is Critical for Responsiveness to IFN ‐α Plus Anti‐ PD ‐1 in Colorectal Cancer
Cancer Medicine · 2025
DOI: 10.1002/cam4.70802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Haihang Nie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DEAD Box Protein 58, Interferon-alpha, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Guidance Project of Scientific Research Plan of the Health Commission of Hubei Province, The Science and Technology Innovation Cultivation Fund of Zhongnan Hospital, Wuhan University, Wuhan University Independent Scientific Research Young Teachers Project.
Abstract (Originalsprache)
Backgrounds Immunotherapy is a promising and effective approach that has achieved significant curative effects in colorectal cancer (CRC). Recently, retinoic acid‐inducible gene I (RIG‐I) has been shown to play a critical role in tumor immunity. However, the correlation between RIG‐I and immunotherapy in CRC remains unclear.
Methods
RIG‐I expression was measured in CRC and normal samples based on analysis of the public databases, a tissue microarray, and CRC cell lines. The correlation between RIG‐I and immune microenvironment was explored using well‐established biological algorithms and in vitro and in vivo experiments.
Results
We discovered that RIG‐I expression was downregulated in CRC compared with normal samples. The bioinformatic algorithms indicated that high RIG‐I‐expressing samples showed a positive correlation with IFN‐α response and enrichment of antitumor immune cells, especially CD8+ T cells. Furthermore, knockdown of RIG‐I expression efficiently reduced the cell death, STAT1 phosphorylation, and CXCL10/11 expression induced by IFN‐α in CRC cells. Finally, an in vivo study showed that the infiltration of CD3+ CD8+ T cells was significantly decreased in the RIG‐I knockout group. An animal model further confirmed that the inhibition of tumor growth induced by IFN‐α plus anti‐PD‐1 therapy was dependent on RIG‐I expression.
Conclusion
RIG‐I is a promising biomarker for CRC immunotherapy, which provides a novel concept for combinatorial immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Hubei Provincial Clinical Research Center for Intestinal and Colorectal Diseases, Wuhan, China.
- Hubei Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Pain, Renmin Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Qiu Zhao
Förderung
- the Guidance Project of Scientific Research Plan of the Health Commission of Hubei Province
- The Science and Technology Innovation Cultivation Fund of Zhongnan Hospital, Wuhan University
- Wuhan University Independent Scientific Research Young Teachers Project
- Natural Science Foundation of Hubei, China
- Hubei Province health and family planning scientific research project
- the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Nie, H., Fang, S., Zhou, R., Jia, Y., Zhou, J., Ning, Y., Yu, Y., Hong, Y., Xu, F., Zhao, Q., Nie, J., & Wang, F. (2025). Upregulation of RIG ‐I is Critical for Responsiveness to IFN ‐α Plus Anti‐ PD ‐1 in Colorectal Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70802
Vancouver
Nie H, Fang S, Zhou R, Jia Y, Zhou J, Ning Y, et al. Upregulation of RIG ‐I is Critical for Responsiveness to IFN ‐α Plus Anti‐ PD ‐1 in Colorectal Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.70802
BibTeX
@article{Nie2025,
author = {Nie, Haihang and Fang, Shilin and Zhou, Rui and Jia, Yifan and Zhou, Jingkai and Ning, Yumei and Yu, Yali and Hong, Yuntian and Xu, Fei and Zhao, Qiu and Nie, Jiayan and Wang, Fan},
title = {Upregulation of RIG ‐I is Critical for Responsiveness to IFN ‐α Plus Anti‐ PD ‐1 in Colorectal Cancer},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70802}
}
EUVIMED